BINGHAM KATE
SEC CIK 1185040 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS PLC | Dir | 38.7K | — | $3.05M | 2 | 2021-07-13 | 2021-07-13 |
Most active insiders at BCYC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Kevin | CEO, Dir | — | $258.0K |
| 2 | Skynner Michael | CTO | — | $79.1K |
| 3 | Milnes Alistair | COO | — | $62.0K |
| 4 | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | — | $56.8K |
| 5 | Young Alethia | CFO | — | $54.6K |
| 6 | Thompson Travis Alvin | CFO | — | $27.3K |
| 7 | Perry Jennifer Scott | COO | — | $13.0K |
| 8 | Swanton Robert Charles | Dir | — | $872.10 |
| 9 | Sands Stephen H. | Dir | — | — |
| 10 | Riva Alessandro | Dir | — | — |
BINGHAM KATE made no open-market trades at BCYC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAI | 2021-07-20 | 2021-07-13+ | BCYC | BICYCLE THERAPEUTICS PLC | BINGHAM KATE | Dir | S - Sale | $34.00 | -44.9K | 38.7K | -54% | -$1.53M |
| MI | 2021-07-15 | 2021-07-13+ | BCYC | BICYCLE THERAPEUTICS PLC | BINGHAM KATE | Dir | S - Sale | $34.00 | -44.9K | 38.7K | -54% | -$1.53M |
Purchase Sale Sale after option exercise All abbreviations